AlphaFold

Isomorphic inks deals with Eli Lilly and Novartis for drug discovery

Isomorphic Labs, the London-based, drug discovery–focused spinout of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical

Charm Therapeutics applies AI to complex protein interactions, locking down $50M A round

The world of AI-powered drug discovery keeps expanding as the capabilities of machine learning grow. One approach that seemed unthinkable just a few years ago is simulating the complicated interplays

DeepMind puts the entire human proteome online, as folded by AlphaFold

DeepMind and several research partners have released a database containing the 3D structures of nearly every protein in the human body, as computationally determined by the breakthrough protein foldin

Alphabet’s DeepMind achieves historic new milestone in AI-based protein structure prediction

DeepMind, the AI technology company that’s part of Google parent Alphabet, has achieved a significant breakthrough in AI-based protein structure prediction. The company announced today that its

DeepMind claims early progress in AI-based predictive protein modelling

Google-owned AI specialist, DeepMind, has claimed a “significant milestone” in being able to demonstrate the usefulness of artificial intelligence to help with the complex task of predicti